Clinical Hold – Page 3

FDA puts Zafgen’s obesity drug trial on partial hold

Clinical Hold, Clinical Trials, Deaths, Health, Obesity, Prader-Willi Syndrome, R&D, Stocks, Stocks, Studies

Zafgen Inc said the U.S. Food and Drug Administration had put a late-stage trial of its obesity drug on partial hold, two days after the drug developer reported the death […]

AstraZeneca pauses two lung cancer drug combination trials

Clinical Hold, Clinical Trials, Forecasts, Genetics, Health, Immuno-oncology, Lung Cancer, Lung Disease, Mutations, Non-Small Cell Lung Cancer (NSCLC), PD-1/PD-L1 inhibitors, Potential Blockbusters, R&D, Studies

AstraZeneca has temporarily halted two clinical trials combining experimental drugs to treat lung cancer, following reports of lung disease in some patients, the company said on Friday. The trials involve […]

FDA puts clinical hold on Advaxis cancer drug

Cervical Cancer, Clinical Hold, Drug Safety, FDA/Regulatory, Health, HPV, Human Papilloma Virus-associated cancers, R&D, Shares, Shares, Studies

Advaxis Inc said the U.S. Food and Drug Administration has put on hold the mid-stage trials of its experimental cancer drug after a patient died, sending its shares down 27 […]